In this study, we define a list of 227 genes (Table S3) that are differentially expressed in CML CD34+ cells but are not affected by TKI treatment using pre-existing microarray datasets. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.